These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17414083)

  • 21. Toll-like receptors in dermatology.
    Mempel M; Kalali BN; Ollert M; Ring J
    Dermatol Clin; 2007 Oct; 25(4):531-40, viii. PubMed ID: 17903612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel inhibitory peptide of Toll-like receptor signaling limits lipopolysaccharide-induced production of inflammatory mediators and enhances survival in mice.
    Tsung A; McCoy SL; Klune JR; Geller DA; Billiar TR; Hefeneider SH
    Shock; 2007 Apr; 27(4):364-9. PubMed ID: 17414417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent insights into the pathogenesis of severe sepsis.
    Tetta C; Fonsato V; Ronco C; Camussi G
    Crit Care Resusc; 2005 Mar; 7(1):32-9. PubMed ID: 16548817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
    Frantz S; Ertl G; Bauersachs J
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR signaling pathway in patients with sepsis.
    Salomão R; Martins PS; Brunialti MK; Fernandes Mda L; Martos LS; Mendes ME; Gomes NE; Rigato O
    Shock; 2008 Oct; 30 Suppl 1():73-7. PubMed ID: 18704004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptors.
    Dasari P; Nicholson IC; Zola H
    J Biol Regul Homeost Agents; 2008; 22(1):17-26. PubMed ID: 18394314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.
    Erickson B; Sperber K; Frishman WH
    Cardiol Rev; 2008; 16(6):273-9. PubMed ID: 18923230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock.
    Koch A; Zacharowski K
    Crit Care Med; 2009 Jan; 37(1):346-7. PubMed ID: 19112297
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.
    Chen R; Alvero AB; Silasi DA; Steffensen KD; Mor G
    Oncogene; 2008 Jan; 27(2):225-33. PubMed ID: 18176604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of cytokines and pathogen associated molecular pattern receptors in sepsis].
    Kłuciński P; Martirosian G
    Przegl Epidemiol; 2005; 59(3):695-701. PubMed ID: 16433311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
    Kanzler H; Barrat FJ; Hessel EM; Coffman RL
    Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Toll-like receptor in lung response to pathogens].
    Rivas-Santiago B; Juárez E
    Rev Invest Clin; 2007; 59(6):481-8. PubMed ID: 18402340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis.
    Tidswell M; LaRosa SP
    Expert Rev Anti Infect Ther; 2011 May; 9(5):507-20. PubMed ID: 21609262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis.
    Anand RJ; Kohler JW; Cavallo JA; Li J; Dubowski T; Hackam DJ
    J Pediatr Surg; 2007 Jun; 42(6):927-32; discussion 933. PubMed ID: 17560196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease.
    Mitchell JA; Paul-Clark MJ; Clarke GW; McMaster SK; Cartwright N
    J Endocrinol; 2007 Jun; 193(3):323-30. PubMed ID: 17535871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in Toll-like receptor genes and risk of cancer.
    El-Omar EM; Ng MT; Hold GL
    Oncogene; 2008 Jan; 27(2):244-52. PubMed ID: 18176606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of TLR expression, a new perspective for the role of VIP in immunity.
    Gomariz RP; Arranz A; Juarranz Y; Gutierrez-Cañas I; Garcia-Gomez M; Leceta J; Martínez C
    Peptides; 2007 Sep; 28(9):1825-32. PubMed ID: 17706836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.